Zanidatamab
Zymeworks,Jazz
['zanidatamab', 'zanida', 'zymeworks', 'jazz', '$jazz']
jazz pharmaceuticals and zymeworks present positive pivotal phase 2b trial data at asco 2023 evaluating zanidatamab in her2-amplified biliary tract cancers - health stocks hub $jazz 
Real-Time News, Market Data, Insider Trades, and Stock Quotes for Biotech, Pharma, Medical, and Healthcare Stocks @ https://t.co/Oqp6BRBKy2